Patent · US Active

Antibody binding to carbonic anhydrase and use thereof

US11192959B2 · kind B2 · utility

1Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 14, 2017
Grant dateDec 7, 2021
Priority date
Expiry dateAug 23, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.